EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pharmacokinetics and efficacy of tank-water-administered dabrafenib, a BRAF inhibitor, in a zebrafish model of melanoma

Jenna Villman iD, Nikol Dibus iD, Jonas Huhn iD, Anna-Mari Haapanen-Saaristo iD, Ilia Evstafev iD, Alex M Dickens iD, Oliver Scherf-Clavel iD, Ilkka Paatero iD, Kari J Kurppa iD

Disease Models & Mechanisms · 2026

DOI: 10.1242/dmm.052907 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2026. Verfasst von Jenna Villman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Turku Bioscience Centre, University of Turku and Åbo Akademi University, 20520 Turku, Finland. Hauptthemen laut MEDLINE: Oximes, Zebrafish, Imidazoles, Proto-Oncogene Proteins B-raf. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academy of Finland, Sigrid Juseliuksen Saatia, Jane ja Aatos Erkon Saatia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Zebrafish models are widely used to study BRAF-mutant melanoma biology. However, long-term treatment of adult fish with small-molecule BRAF inhibitors remains challenging, and pharmacokinetic data to inform rational dosing strategies are largely lacking for most small molecules in zebrafish. Here, we assessed the pharmacokinetics, metabolism and efficacy of continuously tank-water-administered dabrafenib, a BRAF inhibitor, in adult zebrafish. Dabrafenib was rapidly absorbed from tank water, reaching efficacious plasma levels within 1 h, but also showed fast elimination kinetics with a half-life of 1.0 h. Most human metabolites of dabrafenib were detected in zebrafish, suggesting conserved metabolic processes. Continuous tank-water administration achieved therapeutically relevant steady-state dabrafenib plasma levels that inhibited BRAF-driven signaling and produced robust efficacy in vivo in a genetic zebrafish model of BRAF-mutant melanoma without apparent toxicity. Together, these results demonstrate that continuous tank-water administration of dabrafenib is a feasible, efficient and well-tolerated dosing strategy in zebrafish melanoma models, and may facilitate dosing of other small-molecule inhibitors, especially those with a short in vivo half-life in zebrafish.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OximesZebrafishImidazolesProto-Oncogene Proteins B-rafMelanomaWaterProtein Kinase InhibitorsAnimalsDisease Models, AnimalHumansMutation

Stichwörter der Autor:innen

BRAFDabrafenibMelanomaPharmacokineticsZebrafish

Substanzen

dabrafenibOximesImidazolesProto-Oncogene Proteins B-rafWaterProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Turku Bioscience Centre, University of Turku and Åbo Akademi University, 20520 Turku, Finland.
  • Institute of Biomedicine and Medicity Research Laboratory, University of Turku, 20520 Turku, Finland.
  • Ludwig-Maximilians-Universität München, Department of Pharmacy, 81377 Munich, Germany.

ORCID-Profile: Jenna Villman, Nikol Dibus, Jonas Huhn, Anna-Mari Haapanen-Saaristo, Ilia Evstafev, Alex M Dickens, Oliver Scherf-Clavel, Ilkka Paatero, Kari J Kurppa

Förderung

  • Academy of Finland
  • Sigrid Juseliuksen Saatia
  • Jane ja Aatos Erkon Saatia
  • Suomen Kulttuurirahasto
  • Research Council of Finland
  • Sigrid Juséliuksen Säätiö
  • Jane ja Aatos Erkon Säätiö
  • Turun Yliopisto

Zitieren

APA

Villman, J., Dibus, N., Huhn, J., Haapanen-Saaristo, A. M., Evstafev, I., Dickens, A. M., Scherf-Clavel, O., Paatero, I., & Kurppa, K. J. (2026). Pharmacokinetics and efficacy of tank-water-administered dabrafenib, a BRAF inhibitor, in a zebrafish model of melanoma. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.052907

Vancouver

Villman J, Dibus N, Huhn J, Haapanen-Saaristo AM, Evstafev I, Dickens AM, et al. Pharmacokinetics and efficacy of tank-water-administered dabrafenib, a BRAF inhibitor, in a zebrafish model of melanoma. Disease Models & Mechanisms. 2026. doi:10.1242/dmm.052907

BibTeX
@article{Villman2026,
  author = {Villman, Jenna and Dibus, Nikol and Huhn, Jonas and Haapanen-Saaristo, Anna-Mari and Evstafev, Ilia and Dickens, Alex M and Scherf-Clavel, Oliver and Paatero, Ilkka and Kurppa, Kari J},
  title = {Pharmacokinetics and efficacy of tank-water-administered dabrafenib, a BRAF inhibitor, in a zebrafish model of melanoma},
  journal = {Disease Models & Mechanisms},
  year = {2026},
  doi = {10.1242/dmm.052907}
}
Kostenlos starten →